# Trade Mark Journal No.2026/006 6 February 2026

## WO0000001897931 (5)

Office of origin: United States of America

Date of International Registration:11 December 2025
Date of designation in the UK: 11 December 2025

Class 5
  Pharmaceutical and veterinary preparations for diseases and conditions associated with exposure to B. anthracis organisms or spores and anthrax vaccines.

Emergent Product Development Gaithersburg Inc.

Representative: Virginia Wolk Marino Crowell & Moring LLP, 300 N. LaSalle Drive,, Suite 2500, Chicago IL 60654, UNITED STATES OF AMERICA